Response to Bandera et al
TO THE EDITOR-We thank Bandera et al for their interesting exploration of the relationship between innate immune activation phenotypes and the failure of immunologic reconstitution after initiation of antiretroviral therapy (ART), in response to our published findings [1] . (Table 1) . When evaluating CD4 count as a continuous variable in unadjusted models, findings were consistent in that CD4 count was inversely correlated with circulating levels of sCD163 (correlation [r] = − 0.162; P < .001), sCD14 (r = − 0.131; P < .001), and IL-6 (r = − 0.237; P < .001). These observed associations support the hypothesis put forth by Bandera et al that innate immune activation may be associated with poor CD4 + T-cell restoration; however, the associations with CD4 count that we found in the SUN Study were generally modest. Importantly, our published findings on associations between monocyte activation and clinical risk biomarkers of inflammation were adjusted for CD4 count, in addition to other important confounders. Ultimately, these data warrant further study to determine whether incomplete 
